HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ELP1
elongator acetyltransferase complex subunit 1
Chromosome 9 Β· 9q31.3
NCBI Gene: 8518Ensembl: ENSG00000070061.16HGNC: HGNC:5959UniProt: A0A6Q8PGW3
182PubMed Papers
22Diseases
0Drugs
432Pathogenic Variants
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
cytosolnucleoplasmelongator holoenzyme complexprotein bindingFamilial dysautonomiaRiley-Day syndromemedulloblastomaAbnormality of the skeletal system
✦AI Summary

ELP1 (elongator acetyltransferase complex subunit 1) is the largest subunit of the evolutionarily conserved Elongator complex, which catalyzes multiple tRNA wobble base modifications essential for translational regulation 1. ELP1 mediates tRNA binding and catalyzes formation of modified uridines (mcm5U, mcm5s2U, ncm5U) at position 34 in tRNAs 2. The protein regulates Ξ±-tubulin acetylation, which controls microtubule-dependent axonal transport in projection neurons 3. Loss-of-function ELP1 variants cause proteome instability through defective tRNA modifications and impaired translational fidelity 1. Germline ELP1 mutations represent the most common genetic predisposition to Sonic Hedgehog medulloblastoma (MBSHH), accounting for ~30% of cases, with somatic loss of chromosome 9 causing biallelic inactivation 1. ELP1 deficiency increases DNA replication stress and compromises p53 signaling in cerebellar progenitors, explaining MBSHH restriction to the SHH-3 subtype 4. Germline mutations also cause familial dysautonomia (HSAN type 3), an autosomal recessive disorder with profound sensory loss, autonomic dysfunction, and neuronal degeneration 5. The Ashkenazi Jewish founder mutation impairs axonal transport through reduced Ξ±-tubulin acetylation 3. Disease-modifying therapeutics targeting ELP1 deficiency are advancing toward clinical testing 5.

Sources cited
1
ELP1 is the most common medulloblastoma predisposition gene; germline loss-of-function variants account for ~14-40% of SHH medulloblastomas; ELP1 deficiency causes destabilized Elongator complex, loss of tRNA modifications, and proteome instability
PMID: 32296180
2
Elongator complex catalyzes formation of carboxymethyluridine and multiple tRNA modifications (mcm5U, mcm5s2U, ncm5U) at wobble position 34
PMID: 29332244
3
Elongator regulates Ξ±-tubulin acetylation and microtubule-dependent axonal transport; ELP1 loss impairs Atat1 activity; defects occur in familial dysautonomia patient fibroblasts
PMID: 34620845
4
ELP1 mutations cause familial dysautonomia (HSAN type 3); founder mutation in Ashkenazi Jews causes tissue-specific exon 20 skipping and loss of ELP1 function; results in sensory loss, autonomic dysfunction, sudden death risk
PMID: 37204536
5
ELP1 deficiency increases DNA replication stress and genomic instability; compromises p53 signaling in cerebellar progenitors; ELP1-associated medulloblastomas restricted to SHH-3 subtype
PMID: 40378836
Disease Associationsβ“˜22
Familial dysautonomiaOpen Targets
0.79Strong
Riley-Day syndromeOpen Targets
0.74Strong
medulloblastomaOpen Targets
0.71Strong
Abnormality of the skeletal systemOpen Targets
0.45Moderate
primary dysautonomiaOpen Targets
0.41Moderate
mathematical abilityOpen Targets
0.40Weak
hereditary sensory and autonomic neuropathyOpen Targets
0.37Weak
open-angle glaucomaOpen Targets
0.35Weak
smoking initiationOpen Targets
0.22Weak
aortic diseaseOpen Targets
0.20Weak
attention deficit hyperactivity disorderOpen Targets
0.20Weak
substance abuseOpen Targets
0.20Weak
Charcot-Marie-Tooth diseaseOpen Targets
0.15Weak
Gaucher diseaseOpen Targets
0.11Weak
Fabry diseaseOpen Targets
0.11Weak
neoplasmOpen Targets
0.09Suggestive
Mobius syndromeOpen Targets
0.08Suggestive
neuroblastomaOpen Targets
0.08Suggestive
Alzheimer diseaseOpen Targets
0.07Suggestive
infectionOpen Targets
0.06Suggestive
MedulloblastomaUniProt
Neuropathy, hereditary sensory and autonomic, 3UniProt
Pathogenic Variants432
NM_003640.5(ELP1):c.396_430delinsTTAGAGA (p.Leu133_Leu144delinsTer)Likely pathogenic
Medulloblastoma|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 133
NM_003640.5(ELP1):c.1854+1G>ALikely pathogenic
Familial dysautonomia|Medulloblastoma;Familial dysautonomia|not provided|Medulloblastoma
β˜…β˜…β˜†β˜†2026
NM_003640.5(ELP1):c.2860+2T>CLikely pathogenic
Familial dysautonomia|not provided|Medulloblastoma
β˜…β˜…β˜†β˜†2026
NM_003640.5(ELP1):c.2204+6T>CPathogenic
Familial dysautonomia|not provided|Charcot-Marie-Tooth disease|Medulloblastoma|not specified|Medulloblastoma;Familial dysautonomia|Primary dysautonomia|Ovarian serous cystadenocarcinoma|Sarcoma
β˜…β˜…β˜†β˜†2026
NM_003640.5(ELP1):c.2950C>T (p.Gln984Ter)Pathogenic
not specified|Familial dysautonomia|not provided|ELP1-Associated Medulloblastoma
β˜…β˜…β˜†β˜†2026β†’ Residue 984
NM_003640.5(ELP1):c.697dup (p.Thr233fs)Pathogenic
not provided|ELP1-Associated Medulloblastoma|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 233
NM_003640.5(ELP1):c.641del (p.Pro214fs)Pathogenic
Familial dysautonomia|not provided|Medulloblastoma|Medulloblastoma;Familial dysautonomia|not specified|ELP1-Associated Medulloblastoma
β˜…β˜…β˜†β˜†2026β†’ Residue 214
NM_003640.5(ELP1):c.1731_1735del (p.Gln577fs)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 577
NM_003640.5(ELP1):c.1465C>T (p.Gln489Ter)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 489
NM_003640.5(ELP1):c.2824C>T (p.Arg942Ter)Pathogenic
not provided|Medulloblastoma;Familial dysautonomia|Medulloblastoma|not specified|ELP1-Associated Medulloblastoma|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 942
NM_003640.5(ELP1):c.1644-1G>TLikely pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2026
NM_003640.5(ELP1):c.1875_1876insTT (p.Asp626fs)Likely pathogenic
Familial dysautonomia;Medulloblastoma|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 626
NM_003640.5(ELP1):c.3822G>A (p.Trp1274Ter)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2026β†’ Residue 1274
NM_003640.5(ELP1):c.79C>T (p.Arg27Ter)Pathogenic
Familial dysautonomia|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 27
NM_003640.5(ELP1):c.3572+1G>ALikely pathogenic
Familial dysautonomia|not provided|Familial dysautonomia;Medulloblastoma
β˜…β˜…β˜†β˜†2026
NM_003640.5(ELP1):c.882G>A (p.Trp294Ter)Pathogenic
Familial dysautonomia|not specified|ELP1-Associated Medulloblastoma|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 294
NM_003640.5(ELP1):c.969G>A (p.Trp323Ter)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2025β†’ Residue 323
NM_003640.5(ELP1):c.990G>A (p.Trp330Ter)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2025β†’ Residue 330
NM_003640.5(ELP1):c.676C>T (p.Arg226Ter)Pathogenic
not provided|Medulloblastoma;Familial dysautonomia|Familial dysautonomia
β˜…β˜…β˜†β˜†2025β†’ Residue 226
NM_003640.5(ELP1):c.2859T>A (p.Cys953Ter)Pathogenic
not provided|Familial dysautonomia
β˜…β˜…β˜†β˜†2025β†’ Residue 953
View on ClinVar β†—
Related Genes
IKBKGProtein interaction100%CHUKProtein interaction100%DPH3Protein interaction93%ELP2Protein interaction87%ELP6Protein interaction87%ELP4Protein interaction85%
Tissue Expression6 tissues
Ovary
100%
Heart
79%
Bone Marrow
66%
Brain
62%
Liver
61%
Lung
47%
Gene Interaction Network
Click a node to explore
ELP1IKBKGCHUKDPH3ELP2ELP6ELP4
PROTEIN STRUCTURE
Preparing viewer…
PDB8PTX Β· 2.87 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.80LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.68 [0.58–0.80]
RankingsWhere ELP1 stands among ~20K protein-coding genes
  • #2,381of 20,598
    Most Researched182 Β· top quartile
  • #125of 5,498
    Most Pathogenic Variants432 Β· top 5%
  • #6,690of 17,882
    Most Constrained (LOEUF)0.80
Genes detectedELP1
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
PMID: 32296180
Nature Β· 2020
1.00
2
Familial dysautonomia.
PMID: 37204536
Clin Auton Res Β· 2023
0.90
3
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
0.80
4
Advances in the treatment of familial dysautonomia: what does the future hold?
PMID: 40580154
Expert Rev Neurother Β· 2025
0.72
5
PMID: 29290691
Appl Clin Genet Β· 2017
0.70